FR3080278B1 - PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE - Google Patents
PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE Download PDFInfo
- Publication number
- FR3080278B1 FR3080278B1 FR1853165A FR1853165A FR3080278B1 FR 3080278 B1 FR3080278 B1 FR 3080278B1 FR 1853165 A FR1853165 A FR 1853165A FR 1853165 A FR1853165 A FR 1853165A FR 3080278 B1 FR3080278 B1 FR 3080278B1
- Authority
- FR
- France
- Prior art keywords
- cannabidiol
- active
- manufacturing
- active principle
- spheroid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Abstract
Procédé de fabrication d'un sphéroïde comprenant du cannabidiol dans lequel : a) On mélange un principe actif isolé, une solution active d'origine végétale contenant ledit principe actif ou un précurseur de celui-ci, avec une substance absorbante et adsorbante présentant des propriétés plastiques, b) on extrude ledit mélange jusqu'à obtention d'un produit extrudé, c) on sphéronise ledit produit extrudé jusqu'à obtention d'un sphéroïde, caractérisé en ce que ledit principe actif isolé consiste en du cannabidiol et en ce que ladite solution active d'origine végétale consiste en un extrait actif, issu d'un végétal du genre Cannabis sativa L, contenant du cannabidiol et/ou un précurseur de cannabidiol.Process for manufacturing a spheroid comprising cannabidiol in which: a) an isolated active principle, an active solution of plant origin containing said active principle or a precursor thereof, is mixed with an absorbent and adsorbent substance exhibiting properties plastics, b) said mixture is extruded until an extruded product is obtained, c) said extruded product is spheronized until a spheroid is obtained, characterized in that said isolated active principle consists of cannabidiol and in that said active solution of plant origin consists of an active extract, derived from a plant of the genus Cannabis sativa L, containing cannabidiol and / or a cannabidiol precursor.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1853165A FR3080278B1 (en) | 2018-04-11 | 2018-04-11 | PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE |
PCT/IB2019/052937 WO2019198001A1 (en) | 2018-04-11 | 2019-04-10 | Method for producing a spheroid comprising cannabidiol |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1853165 | 2018-04-11 | ||
FR1853165A FR3080278B1 (en) | 2018-04-11 | 2018-04-11 | PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3080278A1 FR3080278A1 (en) | 2019-10-25 |
FR3080278B1 true FR3080278B1 (en) | 2021-04-30 |
Family
ID=66476677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1853165A Active FR3080278B1 (en) | 2018-04-11 | 2018-04-11 | PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR3080278B1 (en) |
WO (1) | WO2019198001A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
FR2794346B1 (en) * | 1999-06-02 | 2004-08-06 | Ile D Inventeurs Apis Spheromo | FORMULATION AND METHOD FOR THE PRODUCTION OF SPHEROIDS FROM A FERMENTED BEVERAGE OR A FERMENTED JUICE FOR EXAMPLE OF WINE |
ES2516693T3 (en) * | 2006-03-16 | 2014-10-31 | Euro-Celtique S.A. | Pharmaceutical spheroids |
WO2008021394A2 (en) * | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
-
2018
- 2018-04-11 FR FR1853165A patent/FR3080278B1/en active Active
-
2019
- 2019-04-10 WO PCT/IB2019/052937 patent/WO2019198001A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR3080278A1 (en) | 2019-10-25 |
WO2019198001A1 (en) | 2019-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ma et al. | Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model | |
BR0306717A (en) | Pharmaceutical dosage forms and methods for producing same | |
CL2019002247A1 (en) | Polyhalite granulation process. | |
BRPI0519860A2 (en) | extruder system and process for fluid extrusion, injector | |
BR112017017574A2 (en) | process for the production of a formaldehyde stabilized urea product. | |
Park et al. | Oligonol promotes anti-aging pathways via modulation of SIRT1-AMPK-Autophagy Pathway | |
FR3080278B1 (en) | PROCESS FOR MANUFACTURING A CANNABIDIOL SPHEROIDE | |
CH708024B8 (en) | Method for producing a pipette. | |
FR3052978B1 (en) | PROCESS FOR OBTAINING A DIGLYCOSIDE-ENRICHED ARMERIA MARITIMA EXTRACT AND ITS USE IN COSMETICS | |
FR3048982B1 (en) | METHOD OF MANUFACTURING PAPER IMPREGNATED BY A SUPERCRITICAL PRESSURE FLUID - IMPREGNATED PAPER, ESPECIALLY COLORED | |
FR3027602B1 (en) | PROCESS FOR THE SYNTHESIS OF A HYDROXYARYL GROUP-CARRYING POLYMER, PRODUCT THEREOF AND COMPOSITION CONTAINING THE SAME | |
FR3069413B1 (en) | HYDROSOLUBLE PROPOLIS EXTRACT, PROCESS FOR OBTAINING AND USE FOR PREVENTING AND / OR COMBATING PLANT DISEASES | |
BRPI0405436A (en) | Process for the production of unsaturated carboxylic acids or unsaturated nitriles | |
WANG et al. | Prospects of obtaining carrageenase from Polar microorganisms | |
FR3027904B1 (en) | PROCESS FOR THE SYNTHESIS OF A HYDROXYARYL GROUP-CARRYING POLYMER, PRODUCT THEREOF AND COMPOSITION CONTAINING THE SAME | |
BR102014017043B8 (en) | DOMESTIC SEWAGE TREATMENT SYSTEM BY BIODIGESTION | |
XIONG | Promotion of Ziyuglycoside I on white blood cells by autophagy pathway | |
Jin et al. | Anti-allergic activity of crystallinity controlled N-acetyl glucosamine | |
Massimino | discovery of terpenoid metabolism in In silico Cannabis sativa | |
EP3485952A3 (en) | Ecological method for improving the availability of active substances from plant materials, use in animal feed and food composition | |
FR3064194B1 (en) | PROCESS FOR PREPARING A TRAPPING MATERIAL OF COMPOUNDS AND MATERIAL THUS OBTAINED | |
Ha | Microfluidic method as a promising technique for synthesizing antimicrobial compounds | |
CH292092A (en) | Process for the production of stable mixtures containing polymers suitable for further processing. | |
Laguta et al. | Antioxidant/reducing properties of the extracts from the genus Vítex plant leaves | |
CN203000955U (en) | Vacuum blood collection tube capable of protecting activity of hirudin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20200228 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 5 |
|
PLFP | Fee payment |
Year of fee payment: 6 |